Serum Glypican-3 and Interleukin-6 Levels in COVID-19 Patients
Journal of Turkish Clinical Biochemistry · 2023
DOI: 10.56615/tkbd.2023.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Turkish Clinical Biochemistry, 2023. Verfasst von Ayşe Basmakcı und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
We aimed to determine the glypican-3 levels in patients diagnosed with COVID-19, compare these values with the healthy controls, and analyze the evaluation of glypican-3 levels with inflammatory markers, including interleukin-6 (IL-6), to determine its role in disease pathogenesis. Material and Methods: A total of 88 participants (58 patients and 30 controls) were included. Medical history and laboratory findings of the population were recorded. Serum glypican-3 and IL-6 levels were analyzed by the Enzyme-linked immunosorbent assay method.
Results
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), C-reactive protein (CRP), D-dimer, ferritin, lactate dehydrogenase (LDH) levels, and IL-6 levels were significantly higher in the COVID-19 patient group than the healthy controls, while glypican-3 levels were significantly lower in the patient group (p
Zitieren
APA
Basmakcı, A., Gürdl, E., Pala, A. S., Kutlu, O., Adaş, M., Şahi, M., İncirku, F., Arabacı, Ç., & Dikker, O. (2023). Serum Glypican-3 and Interleukin-6 Levels in COVID-19 Patients. Journal of Turkish Clinical Biochemistry. https://doi.org/10.56615/tkbd.2023.02
Vancouver
Basmakcı A, Gürdl E, Pala AS, Kutlu O, Adaş M, Şahi M, et al. Serum Glypican-3 and Interleukin-6 Levels in COVID-19 Patients. Journal of Turkish Clinical Biochemistry. 2023. doi:10.56615/tkbd.2023.02
BibTeX
@article{Basmakc2023,
author = {Basmakcı, Ayşe and Gürdl, Esra and Pala, Ayşe Selcen and Kutlu, Orkide and Adaş, Mine and Şahi, Mustafa and İncirku, Fatih and Arabacı, Çiğdem and Dikker, Okan},
title = {Serum Glypican-3 and Interleukin-6 Levels in COVID-19 Patients},
journal = {Journal of Turkish Clinical Biochemistry},
year = {2023},
doi = {10.56615/tkbd.2023.02}
}
EUVIMED